Disease activity in patients with multiple sclerosis treated with alemtuzumab due to a pregnancy desire

被引：0
|
作者：
Tagliani, P. [1 ]
Vidal-Jordana, A. [2 ]
Zabalza, A. [2 ]
Arrambide, G. [2 ]
Rodriguez-Acevedo, B. [2 ]
Rio, J. [2 ]
Galan, I. [2 ]
Castillo, J. [3 ]
Midaglia, L. [4 ]
Cobo Calvo, A. [2 ]
Comabella, M. [2 ]
Nos, C. [2 ]
Auger, C. [5 ]
Rovira, A. [5 ]
Sastre-Garriga, J. [5 ]
Tintore, M. [2 ]
机构：
[1] Vall dHebron Inst Recerca, Barcelona, Spain
[2] Vall dHebron Univ Campus, Dept Neurol Neuroimmunol, Multiple Sclerosis Ctr Catalonia Cemcat, Barcelona, Spain
[3] Neuroimmunol & Multiple Sclerosis Unit Girona, Girona, Spain
[4] Vall Hebron Univ Hosp, Multiple Sclerosis Ctr Catalonia Cemcat, Dept Neurol Neuroimmunol, Barcelona, Spain
[5] Vall Hebron Univ Hosp, Barcelona, Spain
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1119
引用
收藏
页码：647 / 647
页数：1
相关论文
共 50 条
  • [31] Event-driven immunoprofiling can identify disease reactivation in alemtuzumab-treated multiple sclerosis patients
    Ziemssen, T.
    Blankenburg, J.
    Haase, R.
    Akguen, K.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 927 - 927
  • [32] Two-year assessment of No Evidence of Disease Activity (NEDA-3) and disability regression in patients with aggressive multiple sclerosis treated with alemtuzumab
    Prosperini, L.
    Annovazzi, P.
    Ruggieri, S.
    Boffa, L.
    Buscarinu, M. C.
    Gallo, A.
    Matta, M.
    Moiola, L.
    Musu, L.
    Perini, P.
    Avolio, C.
    Barcella, V.
    Bianco, A.
    Farina, D.
    Ferraro, E.
    Francia, A.
    Granella, F.
    Grimaldi, L. M. E.
    Laroni, A.
    Lus, G.
    Patti, F.
    Pucci, E.
    Repice, A. M.
    Sarchielli, P.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 480 - 481
  • [33] Disease activity during pregnancy after fingolimod withdrawal due to planning a pregnancy in women with multiple sclerosis.
    Hemat, S.
    Houtchens, M.
    Vidal-Jordana, A.
    Guger, M.
    Landi, D.
    D'Haeseleer, M.
    Annovazzi, P.
    Tintore, M.
    Thiel, S.
    Gold, R.
    Hellwig, K.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 74 - 75
  • [34] Short-term outcomes of pediatric multiple sclerosis patients treated with alemtuzumab at a Canadian University multiple sclerosis clinic
    Hunt, David Jure
    Traboulsee, Anthony
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2020, 6 (02)
  • [35] Pregnancy as a natural modulator of disease activity in multiple sclerosis
    Neuteboom, R. F.
    Assink, K.
    Laman, J. D.
    van der Spek, P. J.
    Boven, L. A.
    Hintzen, R. Q.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 195 - 195
  • [36] Effects of pregnancy and delivery on disease activity in multiple sclerosis
    Whitaker, JN
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (05): : 339 - 340
  • [37] Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumab
    Sottini, Alessandra
    Quaresima, Virginia
    Barbaro, Mose
    Moiola, Lucia
    Filippi, Massimo
    Malentacchi, Maria
    Capobianco, Marco
    Puthenparampil, Marco
    Gallo, Paolo
    Cocco, Eleonora
    Frau, Jessica
    Zaffaroni, Mauro
    Guaschino, Clara
    Stampatori, Chiara
    Mancinelli, Chiara
    Brambilla, Laura
    Clerici, Valentina Torri
    Vianello, Marika
    Vitetta, Francesca
    Ferraro, Diana
    Rosettani, Pamela
    Danni, Maura Chiara
    Conti, Marta
    Grimoldi, Maria
    Capra, Ruggero
    Imberti, Luisa
    JOURNAL OF NEUROIMMUNOLOGY, 2023, 382
  • [38] A descriptive analysis of infectious adverse events in alemtuzumab-treated multiple sclerosis patients
    Wray, S.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S247 - S247
  • [39] quantification and immunophenotypic characterization of antigen presenting cells in alemtuzumab treated multiple sclerosis patients
    Vicente Mexia Leitao, Maria Joao Nunes
    Silva-Spinola, Anushcka
    Bernardes, Catarina
    Silva, Isabel
    Pascoal, Rui
    Laranjeira, Paula
    Batista, Sonia
    Jacinto Santana, Maria Isabel
    Sousa, Livia Maria
    Baldeiras, Ines
    Paiva, Artur
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1024 - 1025
  • [40] Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab
    Matias-Guiu, Jorge
    Montero-Escribano, Paloma
    Pytel, Vanesa
    Porta-Etessam, Jesus
    Matias-Guiu, Jordi A.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 44
12345